Evidence map›Paper›PMID 37223511›Full record

ArticleGenes & diseases2023

MyD88 in macrophages protects against colitis via inhibiting the activation of NLRP3 inflammasome in epithelial cells.

Shi Liu, Yanmin Wu, Haiqiang Chen, Qi Yuan, Shuang Ge, Lishu Zhang, Lingling Hou, Tian Tian, Jinhua Zhang

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes & diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Shi LiuCollege of Life Science and Bioengineering, Beijing Jiaotong University, Beijing 100044, China.
Yanmin WuCollege of Life Science and Bioengineering, Beijing Jiaotong University, Beijing 100044, China.
Haiqiang ChenCollege of Life Science and Bioengineering, Beijing Jiaotong University, Beijing 100044, China.
Qi YuanCollege of Life Science and Bioengineering, Beijing Jiaotong University, Beijing 100044, China.
Shuang GeNational Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Bio-targeting Theranostics, Guangxi Medical University, Nanning, Guangxi 530021, China.
Lishu ZhangCollege of Life Science and Bioengineering, Beijing Jiaotong University, Beijing 100044, China.
Lingling HouCollege of Life Science and Bioengineering, Beijing Jiaotong University, Beijing 100044, China.
Tian TianCollege of Life Science and Bioengineering, Beijing Jiaotong University, Beijing 100044, China.
Jinhua ZhangCollege of Life Science and Bioengineering, Beijing Jiaotong University, Beijing 100044, China.
Beijing Jiaotong University · CNGuangxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37223511
PMCPMC10201583
OpenAlexW4280551990

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.